Abstract Archidendron clypearia (A. clypearia), a Fabaceae family member, is widely used as an anti-inflammatory herbal medicine; however, its antibacterial and antidiabetic properties have not been extensively investigated. This study aimed to systematically analyze the antibacterial and antidiabetic components of A. clypearia by utilizing a combination of analytical methods. First, ten different polarity extracts were analyzed through ultra-performance liquid chromatography (UPLC), and their antibacterial and antidiabetic activities were evaluated. Then the spectrum–effect relationship between the biological activity and UPLC chromatograms was analyzed by partial least squares regression and gray relational analysis, followed by corresponding validation using isolated components. Finally, network pharmacology and molecular docking were implemented to predict the main antibacterial target components of A. clypearia and the enzyme inhibition active sites of α-amylase and α-glucosidase. P15, P16, and P20 were found to be the antibacterial and antidiabetic active components. The inhibitory effect of 7-O-galloyltricetiflavan (P15) on six bacterial species may be mediated through the lipid and atherosclerosis pathway, prostate cancer, adherens junctions, and targets such as SRC, MAPK1, and AKT1. The molecular docking results revealed that 7-O-galloyltricetiflavan and 7,4′-di-O-galloyltricetiflavan (P16/P20) can bind to α-amylase and α-glucosidase pockets with binding energies lower than −6 kcal/mol. Our study provides guidance for the development of antibacterial and antidiabetic products based on A. clypearia and can be used as a reference for the evaluation of bioactivity of other herbs. Keywords: Archidendron clypearia, spectrum–effect relationship, antibacterial, antidiabetic, network pharmacology, molecular docking 1. Introduction Archidendron clypearia (Jack.) Nielsen (A. clypearia), a member of the Fabaceae family, has been widely used as a traditional medicine for detoxification, cooling, and edema reduction in Southeast Asia because it is composed of abundant polyphenols [[38]1]. The Chinese folklore book “Lu Chuan Ben Cao” records the use of A. clypearia for the treatment of burns and ulcers since the 17th century. Moreover, A. clypearia is reported to have various effects, including anti-inflammatory, antioxidant, antibacterial, and antidiabetic effects. However, its exploitation is mostly based on its overall extract, and the specific efficacy of the components of A. clypearia has not been extensively investigated. Salmonella, Bacillus subtilis, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa are common pathogens that cause diseases such as diarrhea, fever, and pneumonia, and can even endanger human life [[39]2]. A. clypearia is rich in polyphenols that have been widely demonstrated to have antibacterial effects. The common antibacterial mechanisms of polyphenols mainly include cell wall disruption, alteration of cell membrane permeability, cell metabolism changes, and DNA synthesis disruption [[40]3]. The effects of different components of polyphenols on different pathogenic bacteria also vary greatly. Thus, the search for highly active polyphenolic components is significant for promoting the development of antibacterial products. Diabetes mellitus (DM) is a group of clinical syndromes caused by the interaction of genetic and environmental factors. While DM has a complex etiology, it is closely related to the dysregulation of α-glucosidase and α-amylase activity, and the determination of the inhibitory activity of drugs toward these two enzymes is an important indicator of their hypoglycemic ability [[41]4]. Although traditional antidiabetic drugs such as acarbose and metformin are highly effective, they have various side effects including flatulence, indigestion and other gastrointestinal reactions, whereas many herbal medicines have low toxicity and a wide range of efficacy. Therefore, novel antidiabetic drugs based on herbal medicines can be used to overcome the limitations of the current antidiabetic drugs, provide a more diverse choice of treatments, and improve the standard of living of diabetic patients ([42]Figure 1). Figure 1. [43]Figure 1 [44]Open in a new tab Correlation between A. clypearia and the selected targets. The traditional method for screening active substances in natural products is multistep extraction and separation using organic solvents followed by activity determination. However, this method is time-consuming, labor-intensive, environmentally unfriendly, and inefficient. Spectrum–effect relationship analysis is a method for determining active ingredients by correlating the content of the product in the spectrum of the research object with their bioactivity via chemometrics [[45]5]. Spectrum–effect relationship analysis can be carried out on different extracts or extraction sites of the same herb. Spectrum–effect relationship analysis has been widely used in the discovery for active ingredients of various herbal medicines. Network pharmacology was first proposed by Hopkins in 2007 [[46]6]. It is based on the theory of systems biology and integrates the techniques of multiple disciplines such as multidirectional pharmacology, bioinformatics, and computer science to construct a multilevel “disease–target–drug” network in order to explore the correlation between drugs and diseases and elucidate the mechanism of drug action. Network pharmacology has holistic and systematic characteristics that overlap with the multicomponent and multi-action characteristics of Chinese herbal ingredients. Currently, the mechanism of the active components of A. clypearia is poorly understood. We used a combination of network pharmacology and spectrum–effect relationship analysis to construct a “component–target–disease” network for determining the potential active components of A. clypearia, employing tools such as topological parameter analysis, visualization of protein interaction network diagrams, histograms, bubble diagrams, and drug action on target sites to predict the mechanism of action. Molecular docking is the process of finding the optimal binding mode between small molecules (ligands) and biomolecules (receptors) by simulating the geometric and energetic matching of molecules through chemometric methods, and includes the rigid, semi-flexible, and flexible docking methods. Molecular docking can be used to simulate the binding site between a drug molecule and its corresponding ligand and to assess its energy of action; it is beneficial for guiding drug development and elucidating the mechanism of action of a drug [[47]7]. In this study, the main components of 70% aqueous ethanol (EtOH) extracts of A. clypearia were identified, and the spectrum–effect relationship between the biological activity and UPLC chromatograms was analyzed through partial least squares regression (PLSR) and gray relational analysis (GRA). The screening results were validated through pharmacological activity testing of isolated compounds. The mechanism of action of the screened antibacterial substances was also predicted and evaluated by network pharmacology. Furthermore, the enzyme inhibition active sites of α-amylase and α-glucosidase were analyzed by molecular docking. The combination of multiple analytical methods including spectrum–effect relationship analysis, network pharmacology, and molecular docking allows the exploitation of the medicinal value of A. clypearia ([48]Figure 2). Figure 2. [49]Figure 2 [50]Open in a new tab Strategy for studying the antibacterial and antidiabetic components extracted from A. clypearia. 2. Results and Discussion 2.1. Characterization of A. clypearia The S1 extract was analyzed by mass spectroscopy. Based on the relative retention time, mass-to-charge ratio (m/z), number of fragment ions, and literature references, the components of A. clypearia were